Related references
Note: Only part of the references are listed.Retrospective-prospective study of safety and efficacy of sofosbuvir-based direct-acting antivirals in HIV/HCV-coinfected participants with decompensated liver disease pre- or post-liver transplant
Marion G. Peters et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2021)
Temporal Trends and Outcomes in Liver Transplantation for Recipients With HIV Infection in Europe and United States
Isabel Campos-Varela et al.
TRANSPLANTATION (2020)
Nonalcoholic Steatohepatitis Becomes the Leading Indication for Liver Transplant Registrants Among US Adults Born Between 1945 and 1965
Farah Shirazi et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2020)
The Effects of Hepatitis C Infection and Treatment on All-cause Mortality Among People Living With Human Immunodeficiency Virus
Alexander Breskin et al.
CLINICAL INFECTIOUS DISEASES (2019)
National Trends and Long-term Outcomes of Liver Transplant for Alcohol-Associated Liver Disease in the United States
Brian P. Lee et al.
JAMA INTERNAL MEDICINE (2019)
Medical Contraindications to Transplant Listing in the USA: A Survey of Adult and Pediatric Heart, Kidney, Liver, and Lung Programs
Anji Wall et al.
WORLD JOURNAL OF SURGERY (2019)
The Effects of Hepatitis C Treatment Eligibility Criteria on All-cause Mortality Among People With Human Immunodeficiency Virus
Alexander Breskin et al.
CLINICAL INFECTIOUS DISEASES (2019)
Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study
Christian Manzardo et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
Incidence and Risk Factors for Prediabetes and Diabetes Mellitus Among HIV-infected Adults on Antiretroviral Therapy A Systematic Review and Meta-analysis
Jobert Richie Nansseu et al.
EPIDEMIOLOGY (2018)
Sofosbuvir-Based Regimens in HIV/HCV Coinfected Patients After Liver Transplantation: Results From the ANRS CO23 CUPILT Study
Teresa Maria Antonini et al.
TRANSPLANTATION (2018)
Reduction in Liver Transplant Wait-Listing in the Era of Direct-Acting Antiviral Therapy
Jennifer A. Flemming et al.
HEPATOLOGY (2017)
Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes
George Cholankeril et al.
DIGESTIVE DISEASES AND SCIENCES (2017)
Effectiveness of All-Oral Antiviral Regimens in 996 Human Immunodeficiency Virus/Hepatitis C Virus Genotype 1-Coinfected Patients Treated in Routine Practice
Debika Bhattacharya et al.
CLINICAL INFECTIOUS DISEASES (2017)
Sofosbuvir and Daclatasvir in Mono- and HIV-coinfected Patients with Recurrent Hepatitis C After Liver Transplant
Lluis Castells et al.
ANNALS OF HEPATOLOGY (2017)
Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in patients with HIV
Elizabeth C. Verna
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Successful sofosbuvir-based therapy in HIV/hepatitis C virus coinfected liver transplant recipients with recurrent hepatitis C virus infection
Jennifer L. Grant et al.
AIDS (2016)
Treatment of severe recurrent hepatitis C after liver transplantation in HIV infected patients using sofosbuvir-based therapy
I. Campos-Varela et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Trends in Obesity Among Adults in the United States, 2005 to 2014
Katherine M. Flegal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study
Luca Saverio Belli et al.
JOURNAL OF HEPATOLOGY (2016)
Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis
Graham R. Foster et al.
JOURNAL OF HEPATOLOGY (2016)
Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States
Robert J. Wong et al.
GASTROENTEROLOGY (2015)
Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: A prospective cohort study
Lluis Castells et al.
JOURNAL OF HEPATOLOGY (2015)
Sofosbuvir, Simeprevir, and Ribavirin for the Treatment of Hepatitis C Virus Recurrence in Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Liver Transplant Recipients
Isabel Campos-Varela et al.
LIVER TRANSPLANTATION (2015)
Clinical, biochemical and histological differences between HIV-associated NAFLD and primary NAFLD: a case-control study
I. Vodkin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Differential Body Composition Effects of Protease Inhibitors Recommended for Initial Treatment of HIV Infection: A Randomized Clinical Trial
Esteban Martinez et al.
CLINICAL INFECTIOUS DISEASES (2015)
Risk Factors for Fatty Liver in the Multicenter AIDS Cohort Study
Jennifer C. Price et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Peginterferon and Ribavirin for Treatment of Recurrent Hepatitis C Disease in HCV- HIV Coinfected Liver Transplant Recipients
N. Terrault et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
Outcome of HCV/HIV-Coinfected Liver Transplant Recipients: A Prospective and Multicenter Cohort Study
J. M. Miro et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection
Norah A. Terrault et al.
LIVER TRANSPLANTATION (2012)
Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States
Michael R. Charlton et al.
GASTROENTEROLOGY (2011)
Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection
I Bica et al.
CLINICAL INFECTIOUS DISEASES (2001)
Share Paper
